<< Back
Neurogen Corporation Announces Webcast of June 2 Presentation at 8th Annual Friedman Billings Ramsey Growth Investor Conference

BRANFORD, Conn., May 26 /PRNewswire-FirstCall/ -- Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced today that President and CEO William H. Koster, Ph.D will present at the Eighth Annual Friedman Billings Ramsey Growth Investor Conference on Wednesday June 2, 2004 at 4:50 p.m. EDT.

The presentation will be webcast live from the Millennium Broadway Hotel in New York City and may be accessed through the investor relations section of the Company's web site: http://www.neurogen.com or through the FBR website: http://www.fbrcorp.com. The webcast will be archived for 60 days.

FBR focuses its expertise on several industry sectors: consumer, diversified industrials, energy, financial services, healthcare, insurance, real estate, and technology, media and telecommunications.

About Neurogen

Neurogen Corporation targets new small molecule drugs to improve the lives of patients suffering from disorders with significant unmet medical need, currently: inflammation, pain, insomnia, depression, and obesity. Neurogen continues to generate a portfolio of compelling new drug candidates through its Accelerated Intelligent Drug Discovery (AIDD(TM)) system, its expertise in cellular functional assays, and its depth in medicinal chemistry. The Company conducts its drug research and clinical development independently or, on selected programs, collaborates with world-class pharmaceutical companies to access complementary expertise.

SOURCE Neurogen Corporation
CONTACT: Elaine Grimsell Beckwith of Neurogen Corp., +1-203-315-4615,
Web site: http://www.neurogen.com